342 related articles for article (PubMed ID: 16199699)
1. Longitudinal neurodevelopmental evaluation of children with opsoclonus-ataxia.
Mitchell WG; Brumm VL; Azen CG; Patterson KE; Aller SK; Rodriguez J
Pediatrics; 2005 Oct; 116(4):901-7. PubMed ID: 16199699
[TBL] [Abstract][Full Text] [Related]
2. Opsoclonus-ataxia caused by childhood neuroblastoma: developmental and neurologic sequelae.
Mitchell WG; Davalos-Gonzalez Y; Brumm VL; Aller SK; Burger E; Turkel SB; Borchert MS; Hollar S; Padilla S
Pediatrics; 2002 Jan; 109(1):86-98. PubMed ID: 11773546
[TBL] [Abstract][Full Text] [Related]
3. Long-term neurobehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome: relationship to MRI findings and anti-neuronal antibodies.
Hayward K; Jeremy RJ; Jenkins S; Barkovich AJ; Gultekin SH; Kramer J; Crittenden M; Matthay KK
J Pediatr; 2001 Oct; 139(4):552-9. PubMed ID: 11598603
[TBL] [Abstract][Full Text] [Related]
4. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study.
Rudnick E; Khakoo Y; Antunes NL; Seeger RC; Brodeur GM; Shimada H; Gerbing RB; Stram DO; Matthay KK
Med Pediatr Oncol; 2001 Jun; 36(6):612-22. PubMed ID: 11344492
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome in children with opsoclonus-myoclonus and ataxia and coincident neuroblastoma.
Koh PS; Raffensperger JG; Berry S; Larsen MB; Johnstone HS; Chou P; Luck SR; Hammer M; Cohn SL
J Pediatr; 1994 Nov; 125(5 Pt 1):712-6. PubMed ID: 7525913
[TBL] [Abstract][Full Text] [Related]
6. [Opsoclonus myoclonus ataxia syndrome in Israel].
Blumkin L; Lerman-Sagie T
Harefuah; 2010 Jan; 149(1):24-8, 63. PubMed ID: 20422836
[TBL] [Abstract][Full Text] [Related]
7. [A boy with acute cerebellar ataxia without opsoclonus caused by neuroblastoma].
Blokker RS; Smit LM; van den Bos C; Overberg PC; Caron HN; Kaspers GJ
Ned Tijdschr Geneeskd; 2006 Apr; 150(14):799-803. PubMed ID: 16649400
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal assessment of adaptive behavior in infants and young children with newly diagnosed epilepsy: influences of etiology, syndrome, and seizure control.
Berg AT; Smith SN; Frobish D; Beckerman B; Levy SR; Testa FM; Shinnar S
Pediatrics; 2004 Sep; 114(3):645-50. PubMed ID: 15342834
[TBL] [Abstract][Full Text] [Related]
9. A case of opsoclonus-myoclonus-ataxia with neuroblastoma.
Mukherjee A; Mukherjee A; Chakrabarty S
J Indian Med Assoc; 2004 Nov; 102(11):647-8. PubMed ID: 15868878
[TBL] [Abstract][Full Text] [Related]
10. Outcome and prognostic features in opsoclonus-myoclonus syndrome from infancy to adult life.
Brunklaus A; Pohl K; Zuberi SM; de Sousa C
Pediatrics; 2011 Aug; 128(2):e388-94. PubMed ID: 21788225
[TBL] [Abstract][Full Text] [Related]
11. Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies.
Roizen N; Kasza K; Karrison T; Mets M; Noble AG; Boyer K; Swisher C; Meier P; Remington J; Jalbrzikowski J; McLeod R; Kipp M; Rabiah P; Chamot D; Estes R; Cezar S; Mack D; Pfiffner L; Stein M; Danis B; Patel D; Hopkins J; Holfels E; Stein L; Withers S; Cameron A; Perkins J; Heydemann P
Pediatrics; 2006 Aug; 118(2):e379-90. PubMed ID: 16864640
[TBL] [Abstract][Full Text] [Related]
12. Improvement of neurological status and quality of life in children with opsoclonus myoclonus syndrome at long-term follow-up.
Catsman-Berrevoets CE; Aarsen FK; van Hemsbergen ML; van Noesel MM; Hakvoort-Cammel FG; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2009 Dec; 53(6):1048-53. PubMed ID: 19672966
[TBL] [Abstract][Full Text] [Related]
13. Late detection of neuroblastoma in a patient with prolonged cerebellar ataxia without opsoclonus.
Wolff M; Schöning M; Niemann G; Krägeloh-Mann I
Neuropediatrics; 2001 Apr; 32(2):101-3. PubMed ID: 11414640
[TBL] [Abstract][Full Text] [Related]
14. Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome.
Tate ED; Allison TJ; Pranzatelli MR; Verhulst SJ
J Pediatr Oncol Nurs; 2005; 22(1):8-19. PubMed ID: 15574722
[TBL] [Abstract][Full Text] [Related]
15. Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndrome.
Pranzatelli MR; Tate ED; Travelstead AL; Barbosa J; Bergamini RA; Civitello L; Franz DN; Greffe BS; Hanson RD; Hurwitz CA; Kalinyak KA; Kelfer H; Khakoo Y; Mantovani JF; Nicholson SH; Sanders JM; Wegner S
J Pediatr Hematol Oncol; 2006 Sep; 28(9):585-93. PubMed ID: 17006265
[TBL] [Abstract][Full Text] [Related]
16. Neurodevelopmental outcome of infants with meconium aspiration syndrome: report of a study and literature review.
Beligere N; Rao R
J Perinatol; 2008 Dec; 28 Suppl 3():S93-101. PubMed ID: 19057618
[TBL] [Abstract][Full Text] [Related]
17. [Kinsbourne syndrome: review of our cases].
Rodríguez-Barrionuevo AC; Caballero-Morales MA; Delgado-Marqués MP; Mora-Ramírez MD; Martínez-Antón J
Rev Neurol; 1998 Jun; 26(154):956-9. PubMed ID: 9658467
[TBL] [Abstract][Full Text] [Related]
18. Delayed, recurrent opsoclonus-myoclonus syndrome responding to plasmapheresis.
Armstrong MB; Robertson PL; Castle VP
Pediatr Neurol; 2005 Nov; 33(5):365-7. PubMed ID: 16243225
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal assessment of psychological functioning in children after heart or heart-lung transplantation.
Wray J; Radley-Smith R
J Heart Lung Transplant; 2006 Mar; 25(3):345-52. PubMed ID: 16507430
[TBL] [Abstract][Full Text] [Related]
20. Functional outcome at school age of preterm infants with periventricular hemorrhagic infarction.
Roze E; Van Braeckel KN; van der Veere CN; Maathuis CG; Martijn A; Bos AF
Pediatrics; 2009 Jun; 123(6):1493-500. PubMed ID: 19482759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]